In Japan, medical devices are classified into four classes based on risk: Class I (low risk), Class II (medium risk), Class III (high risk), and Class IV (highest risk). Criteria include intended use, invasiveness, duration of use, and potential impact on the... Read More
To maintain MAH/DMAH status for medical devices in Japan, companies must comply with Good Quality Practice (GQP) and Good Vigilance Practice (GVP) standards, ensure proper documentation, maintain a quality management system, and submit periodic safety reports to the Pharmaceuticals and Medical Devices... Read More
The MHLW/PMDA in Japan oversee medical device registration by evaluating safety and efficacy, conducting inspections, issuing approvals, and monitoring post-market performance. They ensure compliance with regulations, manage adverse event reporting, and provide guidance to manufacturers, ensuring that medical devices meet stringent safety... Read More
In Japan, clinical trials for drugs require approval from the Pharmaceuticals and Medical Devices Agency (PMDA), adherence to Good Clinical Practice (GCP) guidelines, ethical review board approval, informed consent from participants, and compliance with the Clinical Trials Act. Trials must also be... Read More
The Ministry of Health, Labour and Welfare (MHLW) in Japan oversees drug regulation by ensuring the safety, efficacy, and quality of pharmaceuticals. The PMDA, under the MHLW, evaluates new drugs, grants approvals, monitors adverse effects, and enforces compliance with standards, thereby safeguarding... Read More
The Japan drug registration dossier requires documents including the Common Technical Document (CTD), which encompasses Module 1 (regional administrative information), Module 2 (summary documents), Module 3 (quality data), Module 4 (non-clinical study reports), and Module 5 (clinical study reports). Additional local regulatory... Read More
Japan’s drug GMP audits require compliance with the Pharmaceuticals and Medical Devices Act, adherence to the Ministry of Health, Labour and Welfare (MHLW) guidelines, proper documentation, quality management systems, validated processes, and regular internal audits. Facilities must ensure product safety, efficacy, and... Read More
In Japan, obtaining reimbursement for medical devices involves submitting an application to the Ministry of Health, Labour and Welfare (MHLW). The device must be evaluated for safety, efficacy, and cost-effectiveness. Upon approval, it is listed in the National Health Insurance (NHI) reimbursement... Read More
The Japan medical device registration dossier requires documents including the application form, device description, manufacturing information, quality management system certification, clinical data, risk analysis, labeling, instructions for use, and proof of compliance with Japanese regulations. Additionally, a Foreign Manufacturer Registration Certificate and... Read More
Japan’s medical device GMP audits require compliance with the Pharmaceuticals and Medical Devices Act (PMD Act), adherence to the Quality Management System (QMS) Ordinance, documentation of manufacturing processes, risk management, and regular internal audits. Additionally, foreign manufacturers must appoint a Marketing Authorization... Read More